-Search query
-Search result
Showing 1 - 50 of 51 items for (author: kondo & k)
EMDB-35535:
Human ornithine transcarbamylase expressed using mRNA lipid nanoparticles in human cells and PEGylated
Method: single particle / : Kondo K, Yamazaki K, Kubara K, Ishii S, Suzuki Y, Miyazaki T, Mitsuhashi K, Ito M, Tsukahara K
EMDB-33643:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816
Method: single particle / : Uchikubo T, Shirouzu M
EMDB-33644:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803
Method: single particle / : Uchikubo T, Shirouzu M
PDB-7y6l:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816
Method: single particle / : Uchikubo T, Shirouzu M
PDB-7y6n:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803
Method: single particle / : Uchikubo T, Shirouzu M
EMDB-35625:
SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (2-up state)
Method: single particle / : Anraku Y, Kita S, Yajima H, Sasaki J, Sasaki-Tabata K, Maenaka K, Hashiguchi T
EMDB-33065:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
Method: single particle / : Kamada K, Shirouzu M
EMDB-33066:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
Method: single particle / : Kamada K, Shirouzu M
EMDB-33067:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
Method: single particle / : Kamada K, Shirouzu M
EMDB-33068:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
Method: single particle / : Kamada K, Shirouzu M
PDB-7x93:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
Method: single particle / : Kamada K, Shirouzu M
PDB-7x94:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
Method: single particle / : Kamada K, Shirouzu M
PDB-7x95:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
Method: single particle / : Kamada K, Shirouzu M
PDB-7x96:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
Method: single particle / : Kamada K, Shirouzu M
EMDB-33059:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354
Method: single particle / : Kamada K, Shirouzu M
EMDB-33060:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159
Method: single particle / : Kamada K, Shirouzu M
EMDB-33061:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188
Method: single particle / : Kamada K, Shirouzu M
EMDB-33062:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326
Method: single particle / : Kamada K, Shirouzu M
EMDB-33063:
The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496
Method: single particle / : Kamada K, Shirouzu M
EMDB-33064:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8w:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8y:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159
Method: single particle / : Kamada K, Shirouzu M
PDB-7x8z:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188
Method: single particle / : Kamada K, Shirouzu M
PDB-7x90:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326
Method: single particle / : Kamada K, Shirouzu M
PDB-7x91:
The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496
Method: single particle / : Kamada K, Shirouzu M
PDB-7x92:
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445
Method: single particle / : Kamada K, Shirouzu M
EMDB-34221:
SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
EMDB-34222:
SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 2)
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
EMDB-34223:
SARS-CoV-2 BA.2.75 spike glycoprotein (1-up state)
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
EMDB-34224:
SARS-CoV-2 BA.2.75 spike glycoprotein in complex with ACE2
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
PDB-8gs6:
Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
Method: single particle / : Anraku Y, Tabata-Sasaki K, Kita S, Fukuhara H, Maenaka K, Hashiguchi T
EMDB-32078:
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
Method: single particle / : Maeda R, Fujita J, Konishi Y, Kazuma Y, Yamazaki H, Anzai I, Yamaguchi K, Kasai K, Nagata K, Yamaoka Y, Miyakawa K, Ryo A, Shirakawa K, Makino F, Matsuura Y, Inoue T, Imura A, Namba K, Takaori-Kondo A
EMDB-32079:
Cryo-EM structure of the SARS-CoV-2 spike protein (3-up RBD) bound to neutralizing nanobodies P86
Method: single particle / : Maeda R, Fujita J, Konishi Y, Kazuma Y, Yamazaki H, Anzai I, Yamaguchi K, Kasai K, Nagata K, Yamaoka Y, Miyakawa K, Ryo A, Shirakawa K, Makino F, Matsuura Y, Inoue T, Imura A, Namba K, Takaori-Kondo A
EMDB-32080:
Cryo-EM structure of the SARS-CoV-2 spike protein (1-up RBD) bound to neutralizing nanobodies P17
Method: single particle / : Maeda R, Fujita J, Konishi Y, Kazuma Y, Yamazaki H, Anzai I, Yamaguchi K, Kasai K, Nagata K, Yamaoka Y, Miyakawa K, Ryo A, Shirakawa K, Makino F, Matsuura Y, Inoue T, Imura A, Namba K, Takaori-Kondo A
EMDB-32081:
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P17
Method: single particle / : Maeda R, Fujita J, Konishi Y, Kazuma Y, Yamazaki H, Anzai I, Yamaguchi K, Kasai K, Nagata K, Yamaoka Y, Miyakawa K, Ryo A, Shirakawa K, Makino F, Matsuura Y, Inoue T, Imura A, Namba K, Takaori-Kondo A
PDB-7vq0:
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
Method: single particle / : Maeda R, Fujita J, Konishi Y, Kazuma Y, Yamazaki H, Anzai I, Yamaguchi K, Kasai K, Nagata K, Yamaoka Y, Miyakawa K, Ryo A, Shirakawa K, Makino F, Matsuura Y, Inoue T, Imura A, Namba K, Takaori-Kondo A
EMDB-20708:
B-Raf:14-3-3 complex
Method: single particle / : Kondo Y, Ognjenovic J, Banerjee S, Karandur D, Merk A, Kulhanek K, Wong K, Roose JP, Subramaniam S, Kuriyan J
PDB-6uan:
B-Raf:14-3-3 complex
Method: single particle / : Kondo Y, Ognjenovic J, Banerjee S, Karandur D, Merk A, Kulhanek K, Wong K, Roose JP, Subramaniam S, Kuriyan J
PDB-5fmw:
The poly-C9 component of the Complement Membrane Attack Complex
Method: single particle / : Dudkina NV, Spicer BA, Reboul CF, Conroy PJ, Lukoyanova N, Elmlund H, Law RHP, Ekkel SM, Kondos SC, Goode RJA, Ramm G, Whisstock JC, Saibil HR, Dunstone MA
EMDB-3235:
Structure of the poly-C9 component of the Complement Membrane Attack Complex
Method: single particle / : Dudkina NV, Spicer BA, Reboul CF, Conroy PJ, Lukoyanova N, Elmlund H, Law RHP, Ekkel SM, Kondos SC, Goode RJA, Ramm G, Whisstock JC, Saibil HR, Dunstone MA
EMDB-2793:
Membrane embedded pleurotolysin pore with 13 fold symmetry
Method: single particle / : Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, Caradoc-Davies TT, Spicer BA, Kleifeld O, Perugini M, Ekkel S, Hatfaludi T, Oliver K, Hotze EM, Tweten RK, Whisstock JC, Topf M, Dunstone MA, Saibil HR
EMDB-2794:
Membrane bound pleurotolysin prepore (TMH1 lock) trapped with engineered disulphide cross-link
Method: single particle / : Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, Caradoc-Davies TT, Spicer BA, Kleifeld O, Perugini M, Ekkel S, Hatfaludi T, Oliver K, Hotze EM, Tweten RK, Whisstock JC, Topf M, Dunstone MA, Saibil HR
EMDB-2795:
Membrane bound pleurotolysin prepore (TMH2 helix lock) trapped with engineered disulphide cross-link
Method: single particle / : Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, Caradoc-Davies TT, Spicer BA, Kleifeld O, Perugini M, Ekkel S, Hatfaludi T, Oliver K, Hotze EM, Tweten RK, Whisstock JC, Topf M, Dunstone MA, Saibil HR
EMDB-2796:
Membrane bound pleurotolysin prepore (TMH2 strand lock) trapped with engineered disulphide cross-link
Method: single particle / : Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, Caradoc-Davies TT, Spicer BA, Kleifeld O, Perugini M, Ekkel S, Hatfaludi T, Oliver K, Hotze EM, Tweten RK, Whisstock JC, Topf M, Dunstone MA, Saibil HR
PDB-4v2t:
Membrane embedded pleurotolysin pore with 13 fold symmetry
Method: single particle / : Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, Caradoc-Davies TT, Spicer BA, Kleifeld O, Perugini M, Ekkel S, Hatfaludi T, Oliver K, Hotze EM, Tweten RK, Whisstock JC, Topf M, Dunstone MA, Saibil HR
PDB-4v3a:
Membrane bound pleurotolysin prepore (TMH1 lock) trapped with engineered disulphide cross-link
Method: single particle / : Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, CaradocDavies TT, Spicer BA, Kleifeld O, Perugini M, Ekkel S, Hatfaludi T, Oliver K, Hotze EM, Tweten RK, Whisstock JC, Topf M, Dunstone MA, Saibil HR
PDB-4v3m:
Membrane bound pleurotolysin prepore (TMH2 helix lock) trapped with engineered disulphide cross-link
Method: single particle / : Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, Caradoc-Davies TT, Spicer BA, Kleifeld O, Perugini M, Ekkel S, Hatfaludi T, Oliver K, Hotze EM, Tweten RK, Whisstock JC, Topf M, Dunstone MA, Saibil HR
PDB-4v3n:
Membrane bound pleurotolysin prepore (TMH2 strand lock) trapped with engineered disulphide cross-link
Method: single particle / : Lukoyanova N, Kondos SC, Farabella I, Law RHP, Reboul CF, Caradoc-Davies TT, Spicer BA, Kleifeld O, Perugini M, Ekkel S, Hatfaludi T, Oliver K, Hotze EM, Tweten RK, Whisstock JC, Topf M, Dunstone MA, Saibil HR
EMDB-1191:
Conformational changes in the AAA ATPase p97-p47 adaptor complex.
Method: single particle / : Beuron F, Dreveny I, Yuan X, Pye VE, McKeown C, Briggs LC, Cliff MJ, Kaneko Y, Wallis R, Isaacson RL, Ladbury JE, Matthews SJ, Kondo H, Zhang X, Freemont PS
EMDB-1192:
Conformational changes in the AAA ATPase p97-p47 adaptor complex.
Method: single particle / : Beuron F, Dreveny I, Yuan X, Pye VE, McKeown C, Briggs LC, Cliff MJ, Kaneko Y, Wallis R, Isaacson RL, Ladbury JE, Matthews SJ, Kondo H, Zhang X, Freemont PS
Pages: